Venous Sinus Thrombosis

Comprehensive Clinical Guide: Cerebral Venous Sinus Thrombosis (CVST)

Cerebral Venous Sinus Thrombosis (CVST) represents a complex, potentially life-threatening cerebrovascular disorder characterized by the formation of thrombi within the dural venous sinuses or cerebral veins. Unlike arterial stroke, which is typically driven by embolic or thrombotic occlusion of supply vessels, CVST involves the obstruction of venous outflow, leading to increased intracranial pressure (ICP), parenchymal edema, and, if untreated, venous infarction or hemorrhage.

While relatively rare compared to ischemic arterial stroke, CVST disproportionately affects younger populations, including women of childbearing age, and carries significant morbidity if not diagnosed promptly. This guide serves as an authoritative clinical reference for medical professionals, detailing the pathophysiology, diagnostic pathways, and management strategies for this critical diagnosis.

1. Etiology and Pathophysiology

The pathophysiology of CVST is multifactorial, usually arising from a confluence of factors known as Virchow’s Triad: stasis of blood flow, endothelial injury, and hypercoagulability.

The Mechanism of Injury

When a thrombus occludes a venous sinus, the primary immediate consequence is an increase in local venous pressure. This leads to:
1. Impaired CSF Absorption: Because CSF is absorbed through the arachnoid granulations into the venous sinuses, obstruction prevents proper drainage, resulting in secondary communicating hydrocephalus and elevated ICP.
2. Blood-Brain Barrier (BBB) Disruption: Increased capillary hydrostatic pressure causes fluid extravasation into the extracellular space, resulting in vasogenic edema.
3. Venous Infarction: As hydrostatic pressure continues to rise, cerebral perfusion pressure decreases, eventually causing cytotoxic edema and venous infarction.
4. Hemorrhagic Transformation: Because venous infarction involves the rupture of capillaries due to extreme pressure, these infarctions are frequently hemorrhagic, which complicates anticoagulation therapy.

Key Risk Factors

2. Clinical Presentation and Staging

CVST is known as "the great masquerader" due to its highly variable clinical presentation. Symptoms depend largely on the location of the thrombus and the speed of onset.

Standard Symptom Profile

• Headache: The most common symptom (present in >90% of cases). It is often progressive, diffuse, and may mimic migraine or tension-type headache.
• Seizures: More common in CVST than in arterial stroke, occurring in approximately 40% of patients.
• Focal Neurological Deficits: Hemiparesis, aphasia, or visual field deficits depending on the affected region.
• Papilledema: A hallmark sign of increased intracranial pressure.
• Encephalopathy: Decreased level of consciousness, confusion, or coma in severe cases.

Clinical Staging/Grading

While no single universal staging system exists, clinicians often utilize the CVST Severity Score to guide prognosis:
* Grade I (Mild): Isolated headache or minor neurological symptoms without parenchymal lesions.
* Grade II (Moderate): Presence of focal deficits or seizures; evidence of parenchymal edema on neuroimaging.
* Grade III (Severe): Altered mental status, coma, or massive intracranial hemorrhage requiring surgical intervention (decompressive hemicraniectomy).

3. Diagnostic Modalities

Prompt imaging is the gold standard for diagnosis. Clinical suspicion must be high in any young patient presenting with new-onset headache and neurological changes.

Key Diagnostic Tests

1. Computed Tomography (CT) / CT Venography (CTV):
   • Non-contrast CT: May show the "dense triangle sign" (hyperdense thrombus in the superior sagittal sinus).
   • CTV: Highly sensitive and considered the primary modality in emergency settings. It reveals the "empty delta sign" (filling defect in the sinus).
2. Magnetic Resonance Imaging (MRI) / MR Venography (MRV):
   • The gold standard. MRI provides detailed information on parenchymal damage (infarction vs. hemorrhage), while MRV confirms the absence of flow in the venous sinuses.
3. Digital Subtraction Angiography (DSA):
   • Reserved for cases where non-invasive imaging is equivocal or if endovascular intervention (thrombectomy/thrombolysis) is planned.

Differential Diagnosis

Clinicians must distinguish CVST from:
* Idiopathic Intracranial Hypertension (Pseudotumor Cerebri).
* Meningitis or Encephalitis.
* Arterial Ischemic Stroke.
* Primary Brain Tumor.
* Posterior Reversible Encephalopathy Syndrome (PRES).

4. Management and Prognosis

Acute Management Strategy

The cornerstone of treatment is anticoagulation, even in the presence of hemorrhagic transformation.

• Anticoagulation: Heparin (LMWH or UFH) is the gold standard. It prevents thrombus propagation and facilitates recanalization.
• Seizure Management: Prophylactic anti-epileptic drugs (AEDs) are often used in patients with supratentorial lesions or seizures.
• ICP Management: For patients with malignant edema, mannitol, hypertonic saline, or decompressive surgery may be necessary.

Long-term Prognosis

The prognosis for CVST is generally favorable compared to arterial stroke, with approximately 80% of patients achieving full recovery if treated early. However, long-term monitoring is required for:
* Recurrent thrombosis.
* Chronic headache.
* Visual impairment due to prolonged papilledema (optic atrophy).
* Cognitive sequelae.

5. Frequently Asked Questions (FAQ)

1. Is anticoagulation safe if the patient has a brain bleed?
Yes. Clinical studies have demonstrated that anticoagulation is safe and effective even in the presence of secondary venous hemorrhagic infarction, as it addresses the underlying cause of the bleed (venous congestion).

2. Why is CVST more common in women?
The increased risk is primarily linked to hormonal fluctuations associated with oral contraceptives, pregnancy, and the postpartum period, which create a hypercoagulable state.

3. What is the "Empty Delta Sign"?
It is a radiological finding on contrast-enhanced CT where the edges of the sinus enhance, but the center (the thrombus) does not, creating a triangular appearance.

4. How long should a patient remain on blood thinners?
If the CVST was provoked by a transient factor (e.g., pregnancy), 3–6 months is standard. If the cause is idiopathic or related to a permanent thrombophilia, indefinite anticoagulation may be required.

5. Can CVST cause long-term vision loss?
Yes. Persistent elevation of intracranial pressure can cause chronic papilledema, leading to optic nerve atrophy and permanent visual field defects.

6. Does CVST always require surgery?
No. Surgical intervention (decompressive hemicraniectomy) is reserved for "malignant" cases involving large infarctions or life-threatening brain edema.

7. Is headache always the first symptom?
In the vast majority of cases, yes. However, it can present with isolated seizures or focal deficits without significant headache, though this is less common.

8. What role do thrombophilias play?
Genetic predispositions like Factor V Leiden significantly increase the risk of thrombus formation, especially when combined with other triggers like dehydration or infection.

9. Can children get CVST?
Yes, it is most common in the neonatal period (often due to dehydration or infection) and again in adolescence.

10. What is the difference between CVST and arterial stroke?
Arterial stroke involves a lack of blood supply (ischemia) to the brain tissue. CVST involves a lack of blood drainage, which leads to backpressure, swelling, and hemorrhage.

6. Risks, Contraindications, and Clinical Pearls

Contraindications to Anticoagulation

While anticoagulation is standard, it may be contraindicated in:
* Active major systemic hemorrhage (e.g., GI bleed).
* Recent neurosurgical procedures.
* Severe thrombocytopenia.

Clinical Pearls for the Specialist

• Think CVST in "Headache Red Flags": Any patient with a "thunderclap" headache, headache associated with seizures, or headache that does not respond to standard analgesics must be screened for CVST.
• Hydration is Key: In pediatric and elderly populations, dehydration is a major, often overlooked, trigger for venous sinus thrombosis.
• Monitor Vision: Always perform a funduscopic exam. The presence of papilledema is a clinical emergency requiring urgent intervention to prevent permanent blindness.

Summary Table: CVST vs. Arterial Stroke

This guide provides a foundational overview for the clinical management of Venous Sinus Thrombosis. Because of the high variability in patient presentation and the potential for rapid neurological deterioration, a high index of clinical suspicion combined with aggressive, early imaging remains the primary defense against long-term disability.